Stocksigma LogoStocksigma Logo

Bafna Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)

■ Revenue: 4,767 (+34.4% YoY | +79.3% QoQ) ■ EBITDA: 860 (+100.9% YoY | +875.6% QoQ) ■ EBITDA Margin (%): 18.0 (+597 bps YoY | +1473 bps QoQ) ■ PAT: 685

Bafna Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)

Bafna Pharmaceuticals Ltd · Outcome · 11 Nov 2026, 10:16 pm

Bafna Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs) ■ Revenue: 4,767 (+34.4% YoY | +79.3% QoQ) ■ EBITDA: 860 (+100.9% YoY | +875.6% QoQ) ■ EBITDA Margin (%): 18.0 (+597 bps YoY | +1473 bps QoQ) ■ PAT: 685 (+119.1% YoY | +9018.8% QoQ) ■ EPS (INR): 2.89 (+118.9% YoY | +9533.3% QoQ)

Original exchange filing (PDF)

More announcements from Bafna Pharmaceuticals Ltd

All Bafna Pharmaceuticals Ltd announcements